(Q34416444)

2 August 2017

1 reference

title

Review of treatment options for refractory epilepsy: new medications and vagal nerve stimulation (English)

1 reference

2 August 2017

Cramer JA

1

1 reference

2 August 2017

Ben Menachem E

series ordinal

2

1 reference

2 August 2017

French J

series ordinal

3

1 reference

2 August 2017

language of work or name

1 reference

1 November 2001

1 reference

2 August 2017

1 reference

2 August 2017

volume

47

1 reference

2 August 2017

issue

1-2

1 reference

2 August 2017

page(s)

17-25

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900286-8

2 August 2017

1 reference

7 January 2021

The medical dictionary for regulatory activities (MedDRA).

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900286-8

7 January 2021

Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900286-8

7 January 2021

A method of quantification for the evaluation of antiepileptic drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900286-8

7 January 2021

New antiepileptic drugs: comparison of key clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900286-8

7 January 2021

Reassessment: vagus nerve stimulation for epilepsy: a report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900286-8

7 January 2021

Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900286-8

7 January 2021

The new antiepileptic drugs: a systematic review of their efficacy and tolerability

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900286-8

7 January 2021

Zonisamide: Pharmacology and Clinical Efficacy in Epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900286-8

7 January 2021

Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900286-8

7 January 2021

A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900286-8

7 January 2021

Oxcarbazepine: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900286-8

7 January 2021

Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. European Levetiracetam Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900286-8

7 January 2021

A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures. The Vagus Nerve Stimulation Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900286-8

7 January 2021

10.1016/S0920-1211(01)00286-8

Identifiers

DOI

1 reference

2 August 2017

1 reference